Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, WA, Cambridge, MA, South San Francisco, CA, Bothell, WA and Rochester, NY.
Minimum 15 minutes delayed. Source:
News Releases
Nov 08, 2024
Nov 04, 2024
Sep 30, 2024
Events
Oct 1, 2024 at 1:00 PM EDT
Sep 9, 2024 at 12:30 PM EDT
Sep 5, 2024 at 3:00 PM EDT
SEC Filings
Filing date | Description | Form |
---|---|---|
An amendment to the SC 13G filing |
SC 13G/A | |
An amendment to the SC 13G filing |
SC 13G/A | |
An amendment to the SC 13G filing |
SC 13G/A |